Vastagbélrák: vizsgálatok itt: Kína
616 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleThe Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-preserving Surgery
- Where
- Changchun
- Életkor
- 18 év to 75 év
- People
- 520
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07369531 - No phaseNot yet taking people in KínaThe Application of a Novel Endoluminal Robotic System for Colorectal Endoscopic Submucosal Dissection
- Where
- Hong Kong
- Életkor
- 18 év and over
- People
- 10
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07486180 - 3. fázisTaking peopleA Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 430
- Run by
- Chipscreen Biosciences, Ltd.
See details and how to joinNCT06497985 - 3. fázisNot yet taking people in KínaA Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Jinan, Jining, Kunming, Langfang, Lanzhou, Linyi, Meizhou, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Tianjin, Ürümqi, Wuhan, Xiamen, Xi'an, Xi’an, Xining, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 142
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT07483684 - 2. fázisTaking peopleNeoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Hong Qiu
See details and how to joinNCT07478731 - No phaseTaking peopleSCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 49
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07474103 - 2. fázisTaking peopleTolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma
- Where
- Chongqing
- Életkor
- 18 év to 80 év
- People
- 106
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07468630 - No phaseNot yet taking people in KínaConstruction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 200
- Run by
- Sun Yat-sen University
See details and how to joinNCT07463690 - 2. fázisTaking peopleNeoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 50
- Run by
- Seventh Medical Center of PLA General Hospital
See details and how to joinNCT07458529 - 1/2. fázisTaking peopleDual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Beijing Biotech
See details and how to joinNCT07462650 - No phaseNot yet taking people in KínaThe Application of Sentire Surgical System Plus Patient Side Single Arm in Robotic Colorectal Surgery
- Where
- Hong Kong
- Életkor
- 18 év and over
- People
- 12
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07453706 - 2. fázisTaking peopleNeoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)
- Where
- Qingdao
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT06647680 - 2. fázisTaking peopleStudy of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 210
- Run by
- Guangzhou JOYO Pharma Co., Ltd
See details and how to joinNCT06895031 - 2. fázisTaking peopleSerplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Zhejiang University
See details and how to joinNCT05731726 - 3. fázisTaking peopleAK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
- Where
- Guanzhou
- Életkor
- 18 év to 75 év
- People
- 560
- Run by
- Akeso
See details and how to joinNCT06951503 - 3. fázisTaking peopleNeoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 582
- Run by
- Yanhong Deng
See details and how to joinNCT04215731 - 2. fázisTaking peoplePhase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
- Where
- Beijing, Guangzhou
- Életkor
- 18 év and over
- People
- 54
- Run by
- Shanghai EpimAb Biotherapeutics Co., Ltd.
See details and how to joinNCT07314294 - 4. fázisNot yet taking people in KínaFOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Ye Xu
See details and how to joinNCT07446465 - 1/2. fázisTaking peopleCarbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
- Where
- Beijing, Chengdu, Chongqing, Fuzhou, Haikou, Heilongjiang, Henan, Hunan, Shanghai
- Életkor
- 18 év to 80 év
- People
- 54
- Run by
- Sichuan Enray Pharmaceutical Sciences Company
See details and how to joinNCT07433283 - No phaseTaking peopleNeoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 30
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07352280 - 1/2. fázisTaking peopleBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 8 év to 85 év
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT07410494 - 1/2. fázisTaking peopleEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Where
- Beijing
- People
- 83
- Run by
- Essen Biotech
See details and how to joinNCT07410676 - 1. fázisNot yet taking people in KínaPIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07411781 - 2. fázisTaking peopleGSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT06558773 - 2. fázisNot yet taking people in KínaShort-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 19
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07397442